<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>vaccination coverage in British Columbia &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/vaccination-coverage-in-british-columbia/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 14 Oct 2025 04:49:10 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>vaccination coverage in British Columbia &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Immunity to Measles Reaches 90% in British Columbia’s Lower Mainland</title>
		<link>https://bioengineer.org/immunity-to-measles-reaches-90-in-british-columbias-lower-mainland/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 14 Oct 2025 04:49:05 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[age-specific measles antibodies]]></category>
		<category><![CDATA[herd immunity thresholds]]></category>
		<category><![CDATA[measles seroprevalence]]></category>
		<category><![CDATA[vaccination coverage in British Columbia]]></category>
		<category><![CDATA[vaccine hesitancy impact]]></category>
		<guid isPermaLink="false">https://bioengineer.org/immunity-to-measles-reaches-90-in-british-columbias-lower-mainland/</guid>

					<description><![CDATA[In the densely populated Lower Mainland of British Columbia, a recent serological survey has revealed a strikingly high prevalence of measles antibodies among residents, underscoring the region’s robust immunization efforts. Published in the Canadian Medical Association Journal, this population-based, cross-sectional study conducted in August 2024 analyzed blood samples from over 1,000 individuals spanning multiple age [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">280318</post-id>	</item>
	</channel>
</rss>
